항생제 : 기술과 세계 시장

Highlights:

The global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.

Cell wall inhibitor segment of the global antibiotics market reached $21.3 billion in 2022 and should reach $25.9 billion by 2027, with a CAGR of 3.9% during the forecast period of 2022-2027.

Other types segment of the global antibiotics market reached $1.9 billion in 2022 and should reach $2.8 billion by 2027, with a CAGR of 7.3% during the forecast period of 2022-2027.

Report Scope:

This report is focused on newer drugs and innovations in chemical compounds, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control, drugs used for symptomatic treatment and not for the elimination of the virus from the host and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potential of antibiotics with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment are covered, along with a market projection for 2027 and market share assessment for key players.

The report segments the market for antibiotics based on product type, route of administration, application and geographical region. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA and other inhibitors (RNA, mycolic acid, folic acid). Based on route of administration, the market is segmented into oral and topical.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, South America and the Middle East and Africa. Detailed analysis of major countries (U.S., Germany, UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa) will be covered in the regional segment. For market estimates, data will be provided for 2021 as the base year, with estimates for 2022 and forecast value for 2027.

Report Includes:

• 22 data tables and 16 additional tables
• An overview of the global market for antibiotics within the pharmaceutical industry
• Analyses of the global market trends, with data corresponding to market size for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
• Information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
• Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user, and geographical region
• Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
• Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
• Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche AG, Merck & Co. Inc., Pfizer Inc. and Sanofi

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in This Update?
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Overview of Antibiotics
• Common Side Effects of Antibiotics
• Classification of Antibiotics
• Cell Wall Inhibitors
• Protein Inhibitors
• DNA Inhibitors
• Other Antibiotic Classes
• Antibiotic Classification, by Source
• Overview of Gram-Negative and Gram-Positive Bacteria
• Route of Administration
• Trends in the Market for Antibiotics
• New Antibiotic Development
• Antibiotic Drug Development, Smaller Pharmaceutical Firms
• Growing Public/Private Partnerships

Chapter 4 Market Dynamics

• Market Drivers
• Growth Driven by Antibiotics
• Rising Elder Population and Infection Rate
• Increasing Hospital-acquired Infections
• Improved Awareness
• Market Restraints
• Antibiotic-resistant Infections
• Generics
• Declining R&D Investment
• Side Effects of Antibiotics
• Market Opportunities
• Market Expansion
• Novel Antibacterial Agents

Chapter 5 Market Breakdown, by Product

• Global Market for Antibiotics by Product
• Cell Wall Inhibitors
• Protein Inhibitors
• DNA Inhibitors
• Other Types of Inhibitors

Chapter 6 Market Breakdown, by Route of Administration

• Global Market for Antibiotics by Route of Administration
• Oral Antibiotics
• Topical Antibiotics
• Other Routes of Administration

Chapter 7 Market Breakdown, by Region

• Global Market for Antibiotics by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Chapter 8 Impact of COVID-19 on the Pharmaceutical Industry

• Short-term Impact
• Change in Demand
• Shift of Communication and Promotions to Remote Interactions
• R&D Changes
• Long-term Impact
• Delayed Approvals for Non-COVID-related Pharmaceutical Products
• Self-sufficiency in Pharma
• Pharmaceutical Industry Growth Slowdown
• Changes in Consumption Trends in Health-related Products

Chapter 9 Clinical Developments and Pipeline Products

• Respiratory Tract Infections

Chapter 10 Value Chain Analysis

• Introduction
• China: Center of Microbial Threat

Chapter 11 Regulatory Scenario

• FDA and International Regulation
• Recent Regulatory Reforms
• Ketek Case Study

Chapter 12 Competitive Landscape

• Global Company Market Share Analysis
• Mergers, Collaborations, Partnerships and Acquisitions

Chapter 13 Company Profiles

• ABBOTT
• F. HOFFMANN-LA ROCHE AG
• GLAXOSMITHKLINE PLC
• JOHNSON & JOHNSON
• MERCK & CO. INC.
• PFIZER INC.
• SANOFI
• VIATRIS INC.

Chapter 14 Appendix: Acronyms